Table 2.
Cancer Cell | The Role of PC in the Cancer | References |
---|---|---|
Glioblastoma | Inhibition of HDAC6 restores the loss of PC and suppressed the proliferation | [110] |
Esophageal squamous cell carcinoma | KD of PRDX1 restores the loss of PC and suppressed the proliferation | [111] |
Colon cancer | Knockout of TTLL3 causes the loss of PC and promotes tumorigenesis in colon | [112] |
Cholangiocarcinoma | The number of PC is frequently reduced. Inhibition of HDAC6 restores the loss of PC and suppressed the proliferation | [113,114] |
Pancreatic ductal adenocarcinoma | Inhibition of HDAC2 in Panc1 induces ciliogenesis and suppressed the proliferation | [115] |
Clear cell renal carcinoma | PC is lost by inactivation of VHL tumor suppressor | [116] |
Prostate cancer | KD of TACC3 restores the loss of PC and suppressed the proliferation | [117] |
Epithelial ovarian cancer | The number of PC is reduced, which is associated with centrosomal localization of AURKA. KD of AURKA restores the loss of PC and suppressed the oncogenic hedgehog signaling | [118,119] |
Melanoma | Deconstruction of PC is sufficient to drive metastatic formation | [120] |
Chondrosarcoma | Inhibition of HDAC6 restores the loss of PC and suppressed the proliferation | [121] |
Medulloblastoma, basal cell carcinoma | - | - |
with GOF mutation of SMO | PC increase transcriptional activator and stimulate proliferation | [122,123] |
with GOF mutation of GLI2 | PC increase transcriptional suppressor and inhibit proliferation | [122,123] |
PC—primary cilia; KD—knockdown; GOF—gain-of-function.